Assessing the safety of subcutaneous immunotherapy dose adjustments
Authors:
- Christopher M. WebberCWChristopher M. Webber
- Christopher W. CalabriaCCChristopher W. Calabria
- 1 November 2010
- journal article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 105 (5) , 369-375
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading SystemJournal of Allergy and Clinical Immunology, 2010
- A prospective Italian survey on the safety of subcutaneous immunotherapy for respiratory allergyClinical & Experimental Allergy, 2009
- Allergen immunotherapy and asthma: Efficacy, safety, and other considerationsAllergy and Asthma Proceedings, 2008
- Allergen immunotherapy safety: Characterizing systemic reactions and identifying risk factorsAllergy and Asthma Proceedings, 2008
- Allergen immunotherapy: A practice parameter second updateJournal of Allergy and Clinical Immunology, 2007
- Side‐effects of allergen‐specific immunotherapy. A prospective multi‐centre studyClinical & Experimental Allergy, 2006
- Immunotherapy safety: a prospective multi‐centric monitoring study of biologically standardized therapeutic vaccines for allergic diseasesClinical & Experimental Allergy, 2004
- Immunotherapy historical perspectiveAnnals of Allergy, Asthma & Immunology, 2001
- Local reactions during allergen immunotherapy do not require dose adjustmentJournal of Allergy and Clinical Immunology, 2000
- Immunotherapy: A one-year prospective study to evaluate risk factors of systemic reactionsJournal of Allergy and Clinical Immunology, 1995